Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Foghorn Therapeutics Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 61 | 1 | 60 | 0 |
| Shares | 24.9M | 2.50K | 26.3M | +1.38M (+5.5%) |
| Value | $379.1M | $38.0K | $357.4M | −$21.7M (−5.7%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Foghorn Therapeutics Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dynamic Technology Lab Private Ltd | 20,551 | $279.0K | 0.03% |
| HRT Financial LP | 17,651 | $240.0K | 0.00% |
| Tiaa, FSB | 14,469 | $197.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 12,474 | $170.0K | 0.00% |
| XTX Topco Ltd | 11,436 | $156.0K | 0.06% |
| Wedbush Securities Inc | 10,192 | $139.0K | 0.01% |
| Virtus ETF Advisers LLC | 8,198 | $111.0K | 0.04% |
| Point72 Hong Kong Ltd | 203 | $3.00K | 0.00% |
| Lindbrook Capital, LLC | 130 | $2.00K | 0.00% |
| US Bancorp | 3 | $0 | 0.00% |
| Credit Suisse AG | 20 | $0 | 0.00% |
| Ellevest, Inc. | 21 | $0 | 0.00% |
Sold out (12)
Institutions that held Foghorn Therapeutics Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 58,546 | $892.0K |
| Kingdon Capital Management, L.L.C. | 54,241 | $826.0K |
| State of Wisconsin Investment Board | 26,000 | $396.0K |
| J. Goldman & Co LP | 25,488 | $388.0K |
| D. E. Shaw & Co., Inc. | 19,855 | $302.0K |
| Dimensional Fund Advisors LP | 19,758 | $300.0K |
| UBS Group AG | 2,923 | $45.0K |
| Cutler Group LP | 600 | $9.00K |
| High Net Worth Advisory Group LLC | 500 | $8.00K |
| Captrust Financial Advisors | 100 | $2.00K |
| Glassman Wealth Services | 53 | $1.00K |
| Simplex Trading, LLC | 42 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Foghorn Therapeutics Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 2,501 | $38.0K |